Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
2 Views
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
-
Category
Show more
Facebook Comments
No comments found